Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Ministry Issues Warning

1 February 2001

People who have an adrenaline kit, which is used for allergic reactions in children, are being urged to ensure the kit contains the appropriate needle for administering the drug.

The warning comes following advice to the Ministry of Health that an adrenaline kit, which does not contain a needle that is suitable for self administration, and is usually intended for use in hospitals only, has been purchased or prescribed to some individuals.

This alert only applies to the Adrenaline Min-i-jet Kit: PHARMACY MEDICINE Adrenaline 1:10,000 (as hydrochloride) 1mg per 10mL Injection (100 microgram/mL) FOR INTRACARDIAL (IC) OR INTRAVENOUS USE Min-i-jet pre-filled syringe CSL

This product is produced specifically for hospital use and is not intended for use by individuals at home. The alert does not apply to the 1:1,000 strength which is supplied with an appropriate needle.

Team Leader Compliance, Peter Pratt said the Adrenaline Min-i-jet Kit 1:10,000 is used for emergency treatment of life-threatening allergic reactions. Without the needle, the medicine cannot be administered.

Anyone who has purchased or been prescribed this adrenaline kit should contact their doctor. There is an appropriate self administering device called EpiPen and EpiPen Junior which are available from pharmacies.

END


Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.